37.0% growth: At WORLD OF MEDICINE, investments in research and development are paying off

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

balance/9-month report

Berlin (euro adhoc) - Listed medical device manufacturer WORLD OF
MEDICINE achieved a 37.0% growth in sales in the 3rd quarter 2007;
cumulatively over nine months, the Group achieved a sales increase of
16.4% to TE25,142. "In the current fiscal year, we have brought a
number of innovations to market-ready status," says Peter P. Wiest,
CEO of WORLD OF MEDICINE. "It is clear that past investments in
research and development are now paying off." The pre-tax sales yield
after nine months equaled 15.6% (same period last year: 5.1%). In
addition, WORLD OF MEDICINE attained proceeds from the sale of its
former subsidiary, IB Laser AG, in the amount of E1.1 million (before
taxes).

| |9M/2007 |9M/2006 Change |
|Sales |25,142 TE |21,596 TE |+ 16.4% |
|EBT |3,927 TE |1,112 TE |+ 2,815TE |
|Pre-tax sales yield|15.6 % |5.1 % |> 100% |
|Earnings per share |0.54 E |0.07 E |> 100% |

"We are concentrating on the marketing of our new products, on further
investments in our core business, and on the area of optical diagnostics with a
focus on oncology, which promises to generate attractive growth opportunities
in the medium term," states Peter P. Wiest. "For the medium to long term, we
are examining the potential synergies and business opportunities that result
from the partnership with ATON GmbH." As previously disclosed, WORLD OF
MEDICINE is raising its targets for the year 2007, based on the positive
business development and the high volume of orders booked. The Management Board

is now projecting a sales increase of at least 10.0% (prior: 4-5%) to
more than E34.0 million, and a pre-tax sales yield of at least 13.0%
(prior: 10.0%).

WORLD OF MEDICINE and its technologies are paving the way in
Minimally Invasive Surgery - or MIS for short. This approach includes
safe and gentle surgical procedures conducted not through major
incisions, but through keyhole or puncture incisions. The Company is
the global market leader in a niche of this future market.

A telephone conference on the quarterly figures is scheduled today at
10:00 a.m. CET for analysts, investors and press representatives. To
participate, please contact WORLD OF MEDICINE directly.

end of announcement euro adhoc 07.11.2007 08:00:00
--------------------------------------------------------------------------------

ots Originaltext: W.O.M. WORLD OF MEDICINE AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade